d[Leu4,Lys8]-VP is a modified peptide incorporating D-configured residues to alter conformational preference and binding behavior. The changes support sequence–orientation studies. Hydrophobic and charged elements maintain biophysical complexity. Researchers employ it in evaluating structural determinants in peptide variants.
CAT No: R0868
CAS No:42061-33-6
Synonyms/Alias:d[Leu4,Lys8]-VP;42061-33-6;d[Leu4,Lys8]VP;1-Deamino-4-leu-8-lys-vasopressin;Vasopressin, 1-deamino-leu(4)-lys(8)-;CHEMBL412972;Vasopressin, 1-deamino-leucyl(4)-lysine(8)-;(desamino-Cys1,Leu4,Lys)vasopressin;(2S)-N-[(2S)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[(4R,7S,10S,13S,16S)-7-(2-amino-2-oxoethyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-10-(2-methylpropyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]pyrrolidine-2-carboxamide;Vasopressin, 1-(3-mercaptopropanoic acid)-4-L-leucine-8-L-lysine-;D[LEU4,LYS8]-VP TFA;BDBM50205309;AKOS024457446;(Deamino-Cys1,Leu4,Lys8)-Vasopressin;FD109910;(Deamino-Cys1,Leu4,Lys8)-Vasopressin trifluoroacetate salt;3-Mercaptopropionyl-Tyr-Phe-Leu-Asn-Cys-Pro-Lys-Gly-NH2;
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.